# Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment

> **NCT01722656** · PHASE4 · COMPLETED · sponsor: **Southern California Desert Retina Consultants, MC** · enrollment: 40 (actual)

## Conditions studied

- Submacular Vascularized Pigment Epithelial Detachments

## Interventions

- **DRUG:** Aflibercept

## Key facts

- **NCT ID:** NCT01722656
- **Lead sponsor:** Southern California Desert Retina Consultants, MC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01722656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01722656, "Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01722656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*